108 related articles for article (PubMed ID: 18575432)
1. [Digestive neoplasms and bevacizumab].
Bennouna J
J Chir (Paris); 2008 Jan; 145 Spec No 1():1S16-20. PubMed ID: 18575432
[No Abstract] [Full Text] [Related]
2. Drug insight: antiangiogenic therapies for gastrointestinal cancers--focus on monoclonal antibodies.
Reinacher-Schick A; Pohl M; Schmiegel W
Nat Clin Pract Gastroenterol Hepatol; 2008 May; 5(5):250-67. PubMed ID: 18382435
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab: one treatment for all the seasons?
Gelibter AJ; Di Segni S; Zeuli M; Cognetti F
J Clin Oncol; 2008 Jan; 26(3):511; author reply 511-2. PubMed ID: 18202430
[No Abstract] [Full Text] [Related]
4. [Bevacizumab. Progress in cancer therapy by antiangiogenesis].
Krämer I; Lipp HP
Med Monatsschr Pharm; 2006 Jul; 29(7):249-54; quiz 255-6. PubMed ID: 16866078
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy.
Ziemssen F; Voelker M; Inhoffen W; Bartz-Schmidt KU; Gelisken F
Eye (Lond); 2007 Aug; 21(8):1125-6. PubMed ID: 17545966
[No Abstract] [Full Text] [Related]
6. Current role of bevacizumab in colorectal cancer.
Saltz L
Clin Adv Hematol Oncol; 2009 Jun; 7(6):375-6. PubMed ID: 19606071
[No Abstract] [Full Text] [Related]
7. Safety of bevacizumab with fluoropyrimidine-based regimens for first-line treatment of metastatic colorectal cancer.
Tyagi P
Clin Colorectal Cancer; 2006 Sep; 6(3):189-91. PubMed ID: 17026787
[No Abstract] [Full Text] [Related]
8. Bevacizumab in the treatment of ovarian cancer.
Han ES; Monk BJ
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1339-45. PubMed ID: 17944559
[TBL] [Abstract][Full Text] [Related]
9. Addition of bevacizumab to chemotherapy for treatment of solid tumors: similar results but different conclusions.
Ocaña A; Amir E; Vera F; Eisenhauer EA; Tannock IF
J Clin Oncol; 2011 Jan; 29(3):254-6. PubMed ID: 21149670
[No Abstract] [Full Text] [Related]
10. Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer.
Thornton AD; Ravn P; Winslet M; Chester K
Br J Surg; 2006 Dec; 93(12):1456-63. PubMed ID: 17115389
[TBL] [Abstract][Full Text] [Related]
11. Endogenous stimulators and inhibitors of angiogenesis in gastrointestinal cancers: basic science to clinical application.
Sund M; Zeisberg M; Kalluri R
Gastroenterology; 2005 Dec; 129(6):2076-91. PubMed ID: 16344073
[TBL] [Abstract][Full Text] [Related]
12. What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?
Han ES; Monk BJ
Gynecol Oncol; 2007 Apr; 105(1):3-6. PubMed ID: 17383545
[No Abstract] [Full Text] [Related]
13. Antitumor benefits from two antiangiogenesis agents.
Expert Rev Anticancer Ther; 2003 Aug; 3(4):425-6. PubMed ID: 12934654
[No Abstract] [Full Text] [Related]
14. Angiogenesis of breast cancer.
Schneider BP; Miller KD
J Clin Oncol; 2005 Mar; 23(8):1782-90. PubMed ID: 15755986
[No Abstract] [Full Text] [Related]
15. Success of bevacizumab trials raises questions for future studies.
Tuma RS
J Natl Cancer Inst; 2005 Jul; 97(13):950-1. PubMed ID: 15998941
[No Abstract] [Full Text] [Related]
16. Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies.
Koontz BF; Miles EF; Rubio MA; Madden JF; Fisher SR; Scher RL; Brizel DM
Head Neck; 2008 Feb; 30(2):262-6. PubMed ID: 17685450
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
Shih T; Lindley C
Clin Ther; 2006 Nov; 28(11):1779-802. PubMed ID: 17212999
[TBL] [Abstract][Full Text] [Related]
18. [Anti-angiogenic therapy for gastrointestinal tumours].
Graepler F; Gregor M; Lauer UM
Z Gastroenterol; 2005 Mar; 43(3):317-29. PubMed ID: 15765305
[TBL] [Abstract][Full Text] [Related]
19. Progression-free survival in bevacizumab-based first-line treatment for patients with metastatic colorectal cancer: is it a really good end point?
Montagnani F; Migali C; Fiorentini G
J Clin Oncol; 2009 Oct; 27(28):e132-3; author reply e134-5. PubMed ID: 19720898
[No Abstract] [Full Text] [Related]
20. Chemotherapy as palliation in advanced colon cancer.
J Support Oncol; 2007 Feb; 5(2):66. PubMed ID: 17348358
[No Abstract] [Full Text] [Related]
[Next] [New Search]